Trial NCT00788125

View at ClinicalTrials.gov 
Org. Study IDs: 07053
Secondary IDs: CA180 121 CDR0000617760 CHNMC-07053 P30CA033572

Last trial update was posted on 2023-07-14

MeSH Interventions

Carboplatin Dasatinib Etoposide Etoposide phosphate Ifosfamide

MeSH Conditions

Central Nervous System Neoplasms Liver Neoplasms Lymphoma Neoplasms Neoplasms, Germ Cell and Embryonal Nervous System Neoplasms Neuroblastoma Sarcoma

Other Conditions

Brain and Central Nervous System Tumors Childhood Germ Cell Tumor Extragonadal Germ Cell Tumor Kidney Cancer Liver Cancer Ovarian Cancer Testicular Germ Cell Tumor Unspecified Childhood Solid Tumor, Protocol Specific

Stopping Reasons

Terminated early due a shift in resources after lackluster performance of the drug.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID